Back to 
TD Waterhouse Canada Inc.
TD Waterhouse Canada Inc.
NGEN3 quarters
Position history for TD Waterhouse Canada Inc.'s holdings in NERVGEN PHARMA CORP
Yes. TD Waterhouse Canada holds 23,800 shares of NGEN (Nervgen Pharma), worth $41,499, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. TD Waterhouse Canada has held NGEN in every 13F on record since Q1 2026, 3 quarterly filings.
Current Value
$41,499
Current Shares
23,800
Total Value Change
-$61,349
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of NGEN: LMR Partners LLP, MARSHALL WACE, LLP, UBS Group AG, BANK OF AMERICA CORP /DE/